Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
Front Immunol ; 14: 1193256, 2023.
Article in English | MEDLINE | ID: mdl-37545509

ABSTRACT

Background: Plasmodium spp. infection triggers the production of inflammatory cytokines that are essential for parasite control, and conversely responsible for symptoms of malaria. Monocytes play a role in host defense against Plasmodium vivax infection and represent the main source of inflammatory cytokines and reactive oxygen species. The anti-inflammatory cytokine IL-10 is a key regulator preventing exacerbated inflammatory responses. Studies suggested that different clinical presentations of malaria are strongly associated with an imbalance in the production of inflammatory and anti-inflammatory cytokines. Methods: A convenience sampling of peripheral blood mononuclear cells from Plasmodium vivax-infected patients and healthy donors were tested for the characterization of cytokine and adenosine production and the expression of ectonucleotidases and purinergic receptors. Results: Here we show that despite a strong inflammatory response, monocytes also bear a modulatory role during malaria. High levels of IL-10 are produced during P. vivax infection and its production can be triggered in monocytes by P. vivax-infected reticulocytes. Monocytes express high levels of ectonucleotidases, indicating their important role in extracellular ATP modulation and consequently in adenosine production. Plasmatic levels of adenosine are not altered in patients experiencing acute malaria; however, their monocyte subsets displayed an increased expression of P1 purinergic receptors. In addition, adenosine decreases Tumor Necrosis Factor production by monocytes, which was partially abolished with the blockage of the A2a receptor. Conclusion: Monocytes have a dual role, attempting to control both the P. vivax infection and the inflammatory response. Purinergic receptor modulators emerge as an untapped approach to ameliorate clinical malaria.


Subject(s)
Malaria, Vivax , Malaria , Humans , Plasmodium vivax , Interleukin-10 , Leukocytes, Mononuclear/metabolism , Malaria, Vivax/parasitology , Cytokines/metabolism , Inflammation
2.
Virol J ; 19(1): 31, 2022 02 22.
Article in English | MEDLINE | ID: mdl-35193667

ABSTRACT

BACKGROUND: The worldwide epidemics of diseases as dengue and Zika have triggered an intense effort to repurpose drugs and search for novel antivirals to treat patients as no approved drugs for these diseases are currently available. Our aim was to screen plant-derived extracts to identify and isolate compounds with antiviral properties against dengue virus (DENV) and Zika virus (ZIKV). METHODS: Seven thousand plant extracts were screened in vitro for their antiviral properties against DENV-2 and ZIKV by their viral cytopathic effect reduction followed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method, previously validated for this purpose. Selected extracts were submitted to bioactivity-guided fractionation using high- and ultrahigh-pressure liquid chromatography. In parallel, high-resolution mass spectrometric data (MSn) were collected from each fraction, allowing compounds into the active fractions to be tracked in subsequent fractionation procedures. The virucidal activity of extracts and compounds was assessed by using the plaque reduction assay. EC50 and CC50 were determined by dose response experiments, and the ratio (EC50/CC50) was used as a selectivity index (SI) to measure the antiviral vs. cytotoxic activity. Purified compounds were used in nuclear magnetic resonance spectroscopy to identify their chemical structures. Two compounds were associated in different proportions and submitted to bioassays against both viruses to investigate possible synergy. In silico prediction of the pharmacokinetic and toxicity (ADMET) properties of the antiviral compounds were calculated using the pkCSM platform. RESULTS: We detected antiviral activity against DENV-2 and ZIKV in 21 extracts obtained from 15 plant species. Hippeastrum (Amaryllidaceae) was the most represented genus, affording seven active extracts. Bioactivity-guided fractionation of several extracts led to the purification of lycorine, pretazettine, narciclasine, and narciclasine-4-O-ß-D-xylopyranoside (NXP). Another 16 compounds were identified in active fractions. Association of lycorine and pretazettine did not improve their antiviral activity against DENV-2 and neither to ZIKV. ADMET prediction suggested that these four compounds may have a good metabolism and no mutagenic toxicity. Predicted oral absorption, distribution, and excretion parameters of lycorine and pretazettine indicate them as candidates to be tested in animal models. CONCLUSIONS: Our results showed that plant extracts, especially those from the Hippeastrum genus, can be a valuable source of antiviral compounds against ZIKV and DENV-2. The majority of compounds identified have never been previously described for their activity against ZIKV and other viruses.


Subject(s)
Dengue Virus , Dengue , Zika Virus Infection , Zika Virus , Animals , Antiviral Agents/chemistry , Chlorocebus aethiops , Dengue/drug therapy , Humans , Vero Cells
3.
Methods Mol Biol ; 2232: 85-112, 2021.
Article in English | MEDLINE | ID: mdl-33161542

ABSTRACT

Plants harbor a large reservoir of fungal diversity, encompassing endophytic, epiphytic, phytopathogenic, and rhizosphere-associated fungi. Despite this diversity, relatively few fungal species have been characterized as sources of bioactive secondary metabolites. The role of secondary metabolites is still not fully understood; however, it is suggested that these metabolites play important roles in defense mechanisms and fungal interactions with other organisms. Hence, fungal secondary metabolites have potential biotechnological applications as prototype molecules for the development of therapeutic drugs. In this chapter, we describe the main methods used for routine fungi isolation, production of crude fungal extracts, and chemical characterization of bioactive compounds. In addition, explicative notes about the steps described are provided to explore the diversity of the endophytic, phytopathogenic, epiphytic, and rhizosphere fungi and to evaluate the biotechnological potential of each group.


Subject(s)
Bioprospecting/methods , Classification/methods , Fungi/genetics , Plants/genetics , Antifungal Agents/chemistry , Endophytes/genetics , Endophytes/growth & development , Fungi/chemistry , Fungi/classification , Plants/microbiology
4.
Nat Prod Res ; 35(16): 2691-2699, 2021 Aug.
Article in English | MEDLINE | ID: mdl-31530021

ABSTRACT

Chagas disease is an illness caused by the protozoan parasite Trypanosoma cruzi. Only two drugs are available, with the drawback of low rate of cure in the chronic phase of the disease and undesirable side effects. These facts highlight the need to find new compounds for Chagas disease chemotherapy. We describe the isolation and identification of an inseparable mixture of two new trixikingolides from Trixis vauthieri, a plant from family Asteraceae, which present outstanding in vitro trypanocidal activity, with IC50 value of 0.053 µM against the intracellular trypomastigotes and amastigotes forms of T. cruzi infecting L929 cells. The IC50 of the mixture against the host cells is 68 times higher and about 70 times more potent than benznidazole, the reference drug used as control at the experiments. The next step, which depends on obtaining larger quantities of the mixture, is to test it on mice infected with T. cruzi.


Subject(s)
Asteraceae , Chagas Disease , Trypanocidal Agents , Trypanosoma cruzi , Animals , Asteraceae/chemistry , Chagas Disease/drug therapy , Mice , Phytochemicals/isolation & purification , Phytochemicals/pharmacology , Trypanocidal Agents/isolation & purification , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects
5.
Extremophiles ; 24(3): 367-376, 2020 May.
Article in English | MEDLINE | ID: mdl-32157393

ABSTRACT

We identified cultivable fungi present in the glacial ice fragments collected in nine sites across Antarctica Peninsula and assessed their abilities to produce bioactive compounds. Three ice fragments with approximately 20 kg were collected, melted and 3 L filtered through of 0.45 µm sterilized membranes, which were placed on the media Sabouraud agar and minimal medium incubated at 10 °C. We collected 66 isolates classified into 27 taxa of 14 genera. Penicillium palitans, Penicillium sp. 1, Thelebolus balaustiformis, Glaciozyma antarctica, Penicillium sp. 7, Rhodotorula mucilaginosa, and Rhodotorula dairenensis had the highest frequencies. The diversity and richness of the fungal community were high with moderate dominance. Penicillium species were present in all samples, with Penicillium chrysogenum showing the broadest distribution. P. chrysogenum, P. palitans, and Penicillium spp. had trypanocidal, leishmanicidal, and herbicidal activities, with P. chrysogenum having the broadest and highest capability. 1H NMR signals revealed the presence of highly functionalized secondary metabolites in the bioactive extracts. Despite extreme environmental conditions, glacial ice harbours a diverse fungal community, including species never before recorded in the Arctic and Antarctica. Among them, Penicillium taxa may represent wild fungal strains with genetic and biochemical pathways that may produce new secondary bioactive metabolites.


Subject(s)
Bioprospecting , Arctic Regions , Fungi , Ice , Mycobiome , Penicillium
6.
Phytother Res ; 33(9): 2319-2328, 2019 09.
Article in English | MEDLINE | ID: mdl-31264271

ABSTRACT

P2X7 is a purinergic receptor involved in important physiological functions and pathological processes, such as inflammation, neurodegeneration, and pain. Despite its relevance, there is no selective antagonist useful in the treatment of diseases related to this receptor. In this context, research for a selective, safe, and potent antagonist compound that can be used in clinical therapy has been growing. In this work, we evaluated the potential antagonistic activity of three fungal extracts, namely, Vishniacozyma victoriae, Metschnikowia australis, and Ascomycota sp., which were discovered in a high-throughput screening campaign to search for new antagonists for P2X7R from natural products. First, the IC50 values of these fungal extracts were determined in J774.G8 (murine macrophage cell line) and U937 (human monocyte cell line) cells through dye uptake assays. The IC50 values of V. victoriae were 2.6 and 0.92 µg/mL, M. australis has IC50 values of 3.8 and 1.5 µg/mL, and Ascomycota sp. showed values of 2.1 and 0.67 µg/mL in J774.G8 and U937 cells, respectively. These extracts also significantly inhibited propidium iodide and Lucifer yellow uptake via P2X7R pore, P2X7R currents in electrophysiology, IL-1ß release, and the production of oxide nitric and reactive oxygen species. The extracts did not cause cytotoxicity within a period of 24 h. The results showed the promising antagonistic activity of these extracts toward P2X7R, thereby indicating that they can be future candidates for phytomedicines with potential clinical applicability.


Subject(s)
Fungi/chemistry , Receptors, Purinergic P2X7/therapeutic use , Animals , Cell Culture Techniques , Drug Discovery , Humans , Mice
7.
Med Mycol ; 57(3): 332-339, 2019 Apr 01.
Article in English | MEDLINE | ID: mdl-29945180

ABSTRACT

Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Latin American countries. Amphotericin B, sulfonamides, and azoles may be used in the treatment of PCM. However, the high toxicity, prolonged course of treatment, and significant frequency of disease relapse compromise their use. Therefore, there is a need to seek new therapeutic options. We conducted tests with thiosemicarbazone of lapachol (TSC-lap) to determine the antifungal activity and phenotypic effects against several isolates of Paracoccidioides spp. In addition, we evaluated the toxicity against murine macrophages and the ability to enhance phagocytosis. Further, we verified that TSC-lap was active against yeasts but did not show any interaction with the drugs tested. The TSC-lap showed no toxicity at the concentration of 40 µg/ml in macrophages, and at 15.6 µg/ml it could increase the phagocytic index. We observed that this compound induced in vitro ultrastructural changes manifested as withered and broken cells beyond a disorganized cytoplasm with accumulation of granules. We did not observe indications of activity in the cell wall, although membrane damages were noted. We observed alterations in the membrane permeability, culminating in a significant increase in K+ efflux and a gradual loss of the cellular content with increase in the concentration of TSC-lap. In addition, we showed a significant reduction of ergosterol amount in the Pb18 membrane. These data reinforce the possible mechanism of action of this compound to be closely associated with ergosterol biosynthesis and reaffirms the antifungal potential of TSC-lap against Paracoccidioides spp.


Subject(s)
Antifungal Agents/pharmacology , Cell Membrane/drug effects , Naphthoquinones/pharmacology , Paracoccidioides/drug effects , Thiosemicarbazones/pharmacology , Animals , Ergosterol/biosynthesis , Macrophages/drug effects , Male , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/microbiology , Phagocytosis/drug effects
8.
J Med Food ; 22(2): 211-224, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30526214

ABSTRACT

P2Y2 and P2Y4 receptors are physiologically activated by uridine 5'-triphosphate (UTP) and are widely expressed in many cell types in humans. P2Y2 plays an important role in inflammation and proliferation of tumor cells, which could be attenuated with the use of antagonists. However, little is known about the physiological functions related to P2Y4, due to the lack of selective ligands for these receptors. This can be solved through the search for novel compounds with antagonistic activity. The aim of this study was to discover new potential antagonist candidates for P2Y2 and P2Y4 receptors from natural products. We applied a calcium measurement methodology to identify new antagonist candidates for these receptors. First, we established optimal conditions for the calcium assay using J774.G8, a murine macrophage cell line, which expresses functional P2Y2 and P2Y4 receptors and then, we performed the screening of plant extracts at a cutoff concentration of 50 µg/mL. ATP and ionomycin, known intracellular calcium inductors, were used to stimulate cells. The calculated EC50 were 11 µM and 103 nM, respectively. These cells also responded to the UTP stimulation with an EC50 of 1.021 µM. Screening assays were performed and a total of 100 extracts from Brazilian plants were tested. Joannesia princeps Vell. (stem) and Peixotoa A. Juss (flower and leaf) extracts stood out due to their ability to inhibit UTP-induced responses without causing cytotoxicity, and presented an IC50 of 32.32, 14.99, and 12.98 µg/mL, respectively. Collectively, our results point to the discovery of potential antagonist candidates from Brazilian flora for UTP-activated receptors.


Subject(s)
Magnoliopsida , Plant Extracts/pharmacology , Plants/chemistry , Receptors, Purinergic P2/metabolism , Uridine Triphosphate/pharmacology , Adenosine Triphosphate , Animals , Brazil , Calcium/metabolism , Flowers , Inhibitory Concentration 50 , Ionomycin , Macrophages/drug effects , Macrophages/metabolism , Mice , Plant Leaves , Uridine
9.
Mem. Inst. Oswaldo Cruz ; 113(2): 102-110, Feb. 2018. tab, graf
Article in English | LILACS | ID: biblio-894895

ABSTRACT

BACKGROUND In a screen of extracts from plants and fungi to detect antileishmanial activity, we found that the ethyl acetate extract of the fungus Nectria pseudotrichia, isolated from the tree Caesalpinia echinata (Brazilwood), is a promising source of bioactive compounds. OBJECTIVES The aims of this study were to isolate and determine the chemical structures of the compounds responsible for the antileishmanial activity of the organic extract from N. pseudotrichia. METHODS Compounds were isolated by chromatographic fractionation using semi-preparative high-performance liquid chromatography, and their chemical structures were determined by analytical and spectral data and by comparison with published data. The antileishmanial activity of the isolated compounds was evaluated in intracellular amastigote forms of Leishmania (Viannia) braziliensis expressing firefly luciferase as reporter gene, and cytotoxicity was determined in Vero and THP-1 mammalian cell lines by MTT assay. FINDINGS Fractionation of the extract yielded seven compounds: 10-acetyl trichoderonic acid A (1), 6′-acetoxy-piliformic acid (2), 5′,6′-dehydropiliformic acid (3), piliformic acid (4), hydroheptelidic acid (5), xylaric acid D (6), and cytochalasin D (7). Compounds 1, 2 and 3 are reported here for the first time. Compounds 1, 2, and 5 were more active, with IC50 values of 21.4, 28.3, and 24.8 µM, respectively, and showed low toxicity to Vero and THP-1 cells. MAIN CONCLUSIONS N. pseudotrichia produces secondary metabolites that are more toxic to intracellular amastigote forms of L. (V.) braziliensis than to mammalian cells.


Subject(s)
Leishmania braziliensis/drug effects , Chromatography, High Pressure Liquid , Toxicity Tests , Caesalpinia/microbiology , Cell Survival , Chlorocebus aethiops , Inhibitory Concentration 50
10.
Mem Inst Oswaldo Cruz ; 113(2): 102-110, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29236928

ABSTRACT

BACKGROUND In a screen of extracts from plants and fungi to detect antileishmanial activity, we found that the ethyl acetate extract of the fungus Nectria pseudotrichia, isolated from the tree Caesalpinia echinata (Brazilwood), is a promising source of bioactive compounds. OBJECTIVES The aims of this study were to isolate and determine the chemical structures of the compounds responsible for the antileishmanial activity of the organic extract from N. pseudotrichia. METHODS Compounds were isolated by chromatographic fractionation using semi-preparative high-performance liquid chromatography, and their chemical structures were determined by analytical and spectral data and by comparison with published data. The antileishmanial activity of the isolated compounds was evaluated in intracellular amastigote forms of Leishmania (Viannia) braziliensis expressing firefly luciferase as reporter gene, and cytotoxicity was determined in Vero and THP-1 mammalian cell lines by MTT assay. FINDINGS Fractionation of the extract yielded seven compounds: 10-acetyl trichoderonic acid A (1), 6'-acetoxy-piliformic acid (2), 5',6'-dehydropiliformic acid (3), piliformic acid (4), hydroheptelidic acid (5), xylaric acid D (6), and cytochalasin D (7). Compounds 1, 2 and 3 are reported here for the first time. Compounds 1, 2, and 5 were more active, with IC50 values of 21.4, 28.3, and 24.8 µM, respectively, and showed low toxicity to Vero and THP-1 cells. MAIN CONCLUSIONS N. pseudotrichia produces secondary metabolites that are more toxic to intracellular amastigote forms of L. (V.) braziliensis than to mammalian cells.


Subject(s)
Caesalpinia/microbiology , Leishmania braziliensis/drug effects , Nectria/chemistry , Trypanocidal Agents/pharmacology , Animals , Cell Survival , Chlorocebus aethiops , Chromatography, High Pressure Liquid , Inhibitory Concentration 50 , Parasitic Sensitivity Tests , Toxicity Tests , Trypanocidal Agents/isolation & purification , Trypanocidal Agents/toxicity , Vero Cells
11.
Parasit Vectors ; 10(1): 300, 2017 Jun 21.
Article in English | MEDLINE | ID: mdl-28637488

ABSTRACT

BACKGROUND: Schistosoma mansoni is a trematode parasite that causes schistosomiasis, one of the most prevalent neglected tropical diseases, leading to the loss of 2.6 million disability-adjusted life years. Praziquantel is the only drug available, and new drugs are required. The most common strategy in schistosomiasis drug discovery is the use of the schistosomula larval-stage for a pre-screen in drug sensitivity assays. However, assessing schistosomula viability by microscopy has always been a limitation to the throughput of such assays. Hence, the development of validated, robust high-throughput in vitro assays for Schistosoma with simple readouts is needed. Here, we present a simple and affordable alternative to assess schistosomula viability. The method employed is based on the hydrosoluble tetrazolium salt XTT which has been widely used in other organisms but has never been used to drug screen in schistosomes. RESULTS: We showed that schistosomula reduce XTT salt to a coloured formazan product and that absorbance levels reflected the viability and parasites number. This XTT viability assay was validated for high throughput screening of compounds in schistosomula, and dose-response curves of compounds could be reproduced. CONCLUSIONS: We conclude that the XTT viability assay could be applied for the screening of large compounds collections in S. mansoni and accelerate the identification of novel antischistosomal compounds.


Subject(s)
Colorimetry/methods , High-Throughput Screening Assays/methods , Schistosoma mansoni/physiology , Tetrazolium Salts , Animals , Biomphalaria , Dose-Response Relationship, Drug , Indicators and Reagents , Inhibitory Concentration 50 , Linear Models , Parasitic Sensitivity Tests , Reproducibility of Results , Schistosoma mansoni/drug effects , Schistosoma mansoni/isolation & purification , Schistosomicides/pharmacology , Sensitivity and Specificity
12.
Rev. patol. trop ; 45(2): 179-191, jun. 2016. tab, ilus
Article in Portuguese | LILACS | ID: biblio-913214

ABSTRACT

A atividade esquistossomicida do carvacrol e do acetato de carvacrol foi avaliada utilizando-se camundongos Swiss, com peso aproximado de 20g, infectados com cercarias de Schistosoma mansoni. Os experimentos in vitro e in vivo foram realizados conforme a metodologia descrita no tópico específico do presente artigo. Nos dois experimentos in vitro, as concentrações foram de 4 µg/mL ou 8µg/mL. Nas experiências in vivo, um grupo de dez animais foi tratado, por via oral, com 300mg/kg durante cinco dias consecutivos e, em outros dois grupos também de dez animais, foram administradas, por via oral, as doses únicas de 15 mg/kg ou 30 mg/kg. Os dois compostos mostraram-se ativos na concentração de 4µg/mL, causando a morte dos vermes adultos de S. mansoni em menos de 24 horas de contato, quando os testes foram realizados in vitro. Nos experimentos in vivo, considerados os três esquemas terapêuticos utilizados, não se observou diferença significativa na eficácia dos compostos. Diante dos resultados obtidos, conclui-se que os compostos estudados são viáveis para estudos in vitro, mas não apresentam atividade in vivo, indicando que testes in vitro não são suficientes para caracterizar um agente esquistossomicida. A falta de atividade in vivo sugere que estes compostos, na forma utilizada, não podem ser considerados como esquistossomicidas para uso clínico. É importante ter em mente que, apesar de útil, a abordagem in vitro é uma simulação da realidade, mas, definitivamente, uma abordagem não substituirá a outra


Subject(s)
Schistosoma mansoni , Schistosomiasis , Drug Therapy
13.
Nat Prod Res ; 30(4): 478-81, 2016.
Article in English | MEDLINE | ID: mdl-25812930

ABSTRACT

Endophytic fungi represent ubiquitous microbial organisms able to live in the tissues of different plants around the world and represent a prolific source of bioactive metabolites. In the present study, the endophytic fungus Aspergillus calidoustus was isolated from the medicinal plant Acanthospermum australe (Asteraceae), and identified using molecular, physiological and morphological methods. A methylene chloride crude extract of A. calidoustus has been produced and subjected to antifungal bioassay-directed fractionation which resulted in the isolation of the two bioactive compounds: ophiobolin K and 6-epi-ophiobolin K. These pure compounds displayed antifungal activity against fungal plant pathogens, protozoal activity against Trypanosoma cruzi, and cytotoxic activity against human tumoral cell lines. The results show that A. calidoustus was able to produce the antifungal and cytotoxic metabolites ophiobolin K and 6-epi-ophiobolin K, which may help the fungus to colonise and occupy the substratum as well as survive in natural environments.


Subject(s)
Antifungal Agents/chemistry , Antimalarials/chemistry , Antineoplastic Agents/chemistry , Aspergillus/chemistry , Sesterterpenes/chemistry , Antifungal Agents/isolation & purification , Antimalarials/isolation & purification , Antineoplastic Agents/isolation & purification , Asteraceae/microbiology , Cell Line, Tumor , Humans
14.
BMC Microbiol ; 14: 331, 2014 Dec 24.
Article in English | MEDLINE | ID: mdl-25539906

ABSTRACT

BACKGROUND: Human T-lymphotropic virus 1 (HTLV-1) has been associated with leukemia/lymphoma (ATL) and myelopathy/tropical spastic paraparesis (HAM/TSP), in addition to other inflammatory diseases as well as infection complications. Therapeutic approaches for HTLV-1-related pathologies are limited. The labdane diterpene myriadenolide (AMY) is a natural product that exhibit biological activities, such as anti-inflammatory and antiviral activity as reported for HIV and herpesvirus. RESULTS: We demonstrated that this natural product was able to inhibit the expression of gag-pol mRNA and substantially reduced the expression of the structural proteins p19 and gp46. Comparison of treated and untreated cells shows that AMY alters both the morphology and the release of viral particles. The Atomic Force Microscopy assay showed that the AMY treatment reduced the number of particles on the cell surface by 47%. CONCLUSION: We demonstrated that the labdane diterpene myriadenolide reduced the expression of the structural proteins and the budding of viral particles, besides induces altered morphogenesis of HTLV-1, conferring on AMY a new antiviral activity that may be useful for the development of new compounds with specific anti-HTLV-1 activity.


Subject(s)
Antiviral Agents/pharmacology , Diterpenes/pharmacology , Human T-lymphotropic virus 1/drug effects , Morphogenesis/drug effects , RNA, Messenger/genetics , Anti-Inflammatory Agents/pharmacology , Biological Factors/pharmacology , Biological Products/pharmacology , Cell Line, Tumor , Humans , Jurkat Cells
15.
Mem. Inst. Oswaldo Cruz ; 108(8): 974-982, 6/dez. 2013. tab, graf
Article in English | LILACS | ID: lil-697147

ABSTRACT

Infusions of Aspidosperma nitidum (Apocynaceae) wood bark are used to treat fever and malaria in the Amazon Region. Several species of this family are known to possess indole alkaloids and other classes of secondary metabolites, whereas terpenoids, an inositol and the indole alkaloids harmane-3 acid and braznitidumine have been described in A. nitidum . In the present study, extracts from the wood bark, leaves and branches of this species were prepared for assays against malaria parasites and cytotoxicity testing using human hepatoma and normal monkey kidney cells. The wood bark extracts were active against Plasmodium falciparum and showed a low cytotoxicity in vitro, whereas the leaf and branch extracts and the pure alkaloid braznitidumine were inactive. A crude methanol extract was subjected to acid-base fractionation aimed at obtaining alkaloid-rich fractions, which were active at low concentrations against P. falciparum and in mice infected with and sensitive Plasmodium berghei parasites. Our data validate the antimalarial usefulness of A. nitidum wood bark, a remedy that can most likely help to control malaria. However, the molecules responsible for this antimalarial activity have not yet been identified. Considering their high selectivity index, the alkaloid-rich fractions from the plant bark might be useful in the development of new antimalarials.


Subject(s)
Animals , Humans , Mice , Antimalarials/pharmacology , Aspidosperma/chemistry , Plant Bark/chemistry , Plant Extracts/pharmacology , Plasmodium berghei/drug effects , Plasmodium falciparum/drug effects , Antimalarials/isolation & purification , Malaria/drug therapy , Malaria/parasitology , Parasitic Sensitivity Tests , Plant Extracts/isolation & purification
17.
Mem Inst Oswaldo Cruz ; 108(3)2013 May.
Article in English | MEDLINE | ID: mdl-23778660

ABSTRACT

Lapachol was chemically modified to obtain its thiosemicarbazone and semicarbazone derivatives. These compounds were tested for antimicrobial activity against several bacteria and fungi by the broth microdilution method. The thiosemicarbazone and semicarbazone derivatives of lapachol exhibited antimicrobial activity against the bacteria Enterococcus faecalis and Staphylococcus aureus with minimal inhibitory concentrations (MICs) of 0.05 and 0.10 µmol/mL, respectively. The thiosemicarbazone and semicarbazone derivatives were also active against the pathogenic yeast Cryptococcus gattii (MICs of 0.10 and 0.20 µmol/mL, respectively). In addition, the lapachol thiosemicarbazone derivative was active against 11 clinical isolates of Paracoccidioides brasiliensis, with MICs ranging from 0.01-0.10 µmol/mL. The lapachol-derived thiosemicarbazone was not cytotoxic to normal cells at the concentrations that were active against fungi and bacteria. We synthesised, for the first time, thiosemicarbazone and semicarbazone derivatives of lapachol. The MICs for the lapachol-derived thiosemicarbazone against S. aureus, E. faecalis, C. gattii and several isolates of P. brasiliensis indicated that this compound has the potential to be developed into novel drugs to treat infections caused these microbes.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Naphthoquinones/pharmacology , Semicarbazones/pharmacology , Thiosemicarbazones/pharmacology , Cryptococcus gattii/drug effects , Enterococcus faecalis/drug effects , Microbial Sensitivity Tests , Paracoccidioides/drug effects , Staphylococcus aureus/drug effects
18.
Mem. Inst. Oswaldo Cruz ; 108(3): 342-351, maio 2013. tab, graf
Article in English | LILACS | ID: lil-676971

ABSTRACT

Lapachol was chemically modified to obtain its thiosemicarbazone and semicarbazone derivatives. These compounds were tested for antimicrobial activity against several bacteria and fungi by the broth microdilution method. The thiosemicarbazone and semicarbazone derivatives of lapachol exhibited antimicrobial activity against the bacteria Enterococcus faecalis and Staphylococcus aureus with minimal inhibitory concentrations (MICs) of 0.05 and 0.10 µmol/mL, respectively. The thiosemicarbazone and semicarbazone derivatives were also active against the pathogenic yeast Cryptococcus gattii (MICs of 0.10 and 0.20 µmol/mL, respectively). In addition, the lapachol thiosemicarbazone derivative was active against 11 clinical isolates of Paracoccidioides brasiliensis, with MICs ranging from 0.01-0.10 µmol/mL. The lapachol-derived thiosemicarbazone was not cytotoxic to normal cells at the concentrations that were active against fungi and bacteria. We synthesised, for the first time, thiosemicarbazone and semicarbazone derivatives of lapachol. The MICs for the lapachol-derived thiosemicarbazone against S. aureus, E. faecalis, C. gattii and several isolates of P. brasiliensis indicated that this compound has the potential to be developed into novel drugs to treat infections caused these microbes.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antifungal Agents/pharmacology , Naphthoquinones/pharmacology , Semicarbazones/pharmacology , Thiosemicarbazones/pharmacology , Cryptococcus gattii/drug effects , Enterococcus faecalis/drug effects , Microbial Sensitivity Tests , Paracoccidioides/drug effects , Staphylococcus aureus/drug effects
19.
Mem Inst Oswaldo Cruz ; 108(8): 974-82, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24402150

ABSTRACT

Infusions of Aspidosperma nitidum (Apocynaceae) wood bark are used to treat fever and malaria in the Amazon Region. Several species of this family are known to possess indole alkaloids and other classes of secondary metabolites, whereas terpenoids, an inositol and the indole alkaloids harmane-3 acid and braznitidumine have been described in A. nitidum . In the present study, extracts from the wood bark, leaves and branches of this species were prepared for assays against malaria parasites and cytotoxicity testing using human hepatoma and normal monkey kidney cells. The wood bark extracts were active against Plasmodium falciparum and showed a low cytotoxicity in vitro, whereas the leaf and branch extracts and the pure alkaloid braznitidumine were inactive. A crude methanol extract was subjected to acid-base fractionation aimed at obtaining alkaloid-rich fractions, which were active at low concentrations against P. falciparum and in mice infected with and sensitive Plasmodium berghei parasites. Our data validate the antimalarial usefulness of A. nitidum wood bark, a remedy that can most likely help to control malaria. However, the molecules responsible for this antimalarial activity have not yet been identified. Considering their high selectivity index, the alkaloid-rich fractions from the plant bark might be useful in the development of new antimalarials.


Subject(s)
Antimalarials/pharmacology , Aspidosperma/chemistry , Plant Bark/chemistry , Plant Extracts/pharmacology , Plasmodium berghei/drug effects , Plasmodium falciparum/drug effects , Animals , Antimalarials/isolation & purification , Humans , Inhibitory Concentration 50 , Malaria/drug therapy , Malaria/parasitology , Mice , Parasitic Sensitivity Tests , Plant Extracts/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL